Literature DB >> 30542978

Japanese Encephalitis Virus NS1' Protein Antagonizes Interferon Beta Production.

Dengyuan Zhou1,2,3, Fan Jia4, Qiuyan Li1,2,3, Luping Zhang1,2,3, Zheng Chen1,2,3, Zikai Zhao1,2,3, Min Cui1,2,3, Yunfeng Song1,2,3, Huanchun Chen1,2,3, Shengbo Cao1,2,3, Jing Ye5,6,7.   

Abstract

Japanese encephalitis virus (JEV) is a mosquito-borne virus and the major cause of viral encephalitis in Asia. NS1', a 52-amino acid C-terminal extension of NS1, is generated with a -1 programmed ribosomal frameshift and is only present in members of the Japanese encephalitis serogroup of flaviviruses. Previous studies demonstrated that NS1' plays a vital role in virulence, but the mechanism is unclear. In this study, an NS1' defected (rG66A) virus was generated. We found that rG66A virus was less virulent than its parent virus (pSA14) in wild-type mice. However, similar mortality caused by the two viruses was observed in an IFNAR knockout mouse model. Moreover, we found that rG66A virus induced a greater type I interferon (IFN) response than that by pSA14, and JEV NS1' significantly inhibited the production of IFN-β and IFN-stimulated genes. Taken together, our results reveal that NS1' plays a vital role in blocking type I IFN production to help JEV evade antiviral immunity and benefit viral replication.

Entities:  

Keywords:  Immune evasion; Japanese encephalitis virus (JEV); NS1′; Type I interferon (IFN-I)

Mesh:

Substances:

Year:  2018        PMID: 30542978      PMCID: PMC6335221          DOI: 10.1007/s12250-018-0067-5

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  8 in total

Review 1.  Mechanisms Underlying Host Range Variation in Flavivirus: From Empirical Knowledge to Predictive Models.

Authors:  Keren Halabi; Itay Mayrose
Journal:  J Mol Evol       Date:  2021-05-31       Impact factor: 2.395

Review 2.  Shiftless, a Critical Piece of the Innate Immune Response to Viral Infection.

Authors:  William Rodriguez; Mandy Muller
Journal:  Viruses       Date:  2022-06-20       Impact factor: 5.818

3.  Japanese Encephalitis Virus NS1' Protein Interacts with Host CDK1 Protein to Regulate Antiviral Response.

Authors:  Qiuyan Li; Dengyuan Zhou; Fan Jia; Luping Zhang; Usama Ashraf; Yunchuan Li; Hongyu Duan; Yunfeng Song; Huanchun Chen; Shengbo Cao; Jing Ye
Journal:  Microbiol Spectr       Date:  2021-11-10

4.  The A137R Protein of African Swine Fever Virus Inhibits Type I Interferon Production via the Autophagy-Mediated Lysosomal Degradation of TBK1.

Authors:  Maowen Sun; Shaoxiong Yu; Hailiang Ge; Tao Wang; Yongfeng Li; Pingping Zhou; Li Pan; Yu Han; Yuying Yang; Yuan Sun; Su Li; Lian-Feng Li; Hua-Ji Qiu
Journal:  J Virol       Date:  2022-04-12       Impact factor: 6.549

5.  JEV Infection Induces M-MDSC Differentiation Into CD3+ Macrophages in the Brain.

Authors:  Nan Zhang; Xiaochen Gao; Weijia Zhang; Junyao Xiong; Xiaojian Cao; Zhen F Fu; Min Cui
Journal:  Front Immunol       Date:  2022-04-21       Impact factor: 8.786

6.  Japanese Encephalitis Virus (JEV) NS1' Enhances the Viral Infection of Dendritic Cells (DCs) and Macrophages in Pig Tonsils.

Authors:  Shengda Xie; Junhui Pan; Qiuting Zhang; Ruting Guan; Xingmiao Yang; Xiaoxiao Yang; Zhenjie Liang; Ruibing Cao
Journal:  Microbiol Spectr       Date:  2022-06-22

7.  Toll-like receptor 2 signaling pathway activation contributes to a highly efficient inflammatory response in Japanese encephalitis virus-infected mouse microglial cells by proteomics.

Authors:  Guanyu Zhao; Yan Gao; Jiaqi Zhang; He Zhang; Changzhan Xie; Fulong Nan; Sheng Feng; Zhuo Ha; Chenghui Li; Xiangyu Zhu; Zhuoxin Li; Ping Zhang; Ying Zhang; Huijun Lu; Ningyi Jin
Journal:  Front Microbiol       Date:  2022-09-12       Impact factor: 6.064

8.  RIPK3 Promotes JEV Replication in Neurons via Downregulation of IFI44L.

Authors:  Peiyu Bian; Chuantao Ye; Xuyang Zheng; Chuanyu Luo; Jiali Yang; Mengyuan Li; Yuan Wang; Jing Yang; Yun Zhou; Fanglin Zhang; Jianqi Lian; Ying Zhang; Zhansheng Jia; Yingfeng Lei
Journal:  Front Microbiol       Date:  2020-03-24       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.